𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adults

✍ Scribed by Phillips, Christine L.; Davies, Stella M.; McMasters, Richard; Absalon, Michael; O'Brien, Maureen; Mo, Jun; Broun, Randall; Moscow, Jeffrey A.; Smolarek, Teresa; Garzon, Ramiro; Blum, William; Schwind, Sebastian; Marcucci, Guido; Perentesis, John P.

Book ID
120595578
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
152 KB
Volume
161
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clofarabine and high-dose cytosine arabi
Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia
✍ Eric Tse; Anskar Y. H. Leung; Joycelyn Sim; Harold K. K. Lee; Herman S. Y. Liu; πŸ“‚ Article πŸ“… 2011 πŸ› Springer 🌐 English βš– 98 KB

Clofarabine (40Β mg/m^2^/day × 5) and high-dose cytosine arabinoside (Ara-C, 1–2Β g/m^2^/day × 5) were used in 10 men and 11 women, at a median age of 45 (22–62) years, with refractory (__N__ = 4) and relapsed (__N__ = 17) acute myeloid leukaemia, after a median of 3 (2–5) prior regimens. Grade 4 myel

FLAG (fludarabine, high-dose cytarabine,
FLAG (fludarabine, high-dose cytarabine, and G-CSF) for refractory and high-risk relapsed acute leukemia in children
✍ McCarthy, A.J.; Pitcher, L.A.; Hann, I.M.; Oakhill, A. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 63 KB πŸ‘ 2 views

Background. The treatment of relapsed and refractory leukemia in children remains a challenge. The morbidity of further chemotherapy is considerable, as most patients have already been exposed to intensive multiagent chemotherapy. The FLAG (fludarabine, high-dose cytarabine, and G-CSF) regimen is as